Financials Shenzhen New Industries Biomedical Engineering Co., Ltd.

Equities

300832

CNE100003T39

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-22 pm EDT 5-day change 1st Jan Change
74.39 CNY -1.67% Intraday chart for Shenzhen New Industries Biomedical Engineering Co., Ltd. -0.12% -4.87%

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 54,455 34,652 39,416 61,443 58,450 - -
Enterprise Value (EV) 1 54,455 34,652 38,934 60,397 56,172 54,996 56,318
P/E ratio 55.5 x 35.6 x 29.7 x 37.2 x 28.4 x 22.4 x 18 x
Yield - 1.36% 1.4% 1.28% 1.68% 2.1% 2.44%
Capitalization / Revenue 24.8 x 13.6 x 12.9 x 15.6 x 11.9 x 9.45 x 7.67 x
EV / Revenue 24.8 x 13.6 x 12.8 x 15.4 x 11.4 x 8.89 x 7.39 x
EV / EBITDA 45.8 x 27.8 x 26.3 x 31.3 x 22.6 x 17.7 x 14.7 x
EV / FCF - - 69.5 x 55.1 x 34.5 x 28.1 x 22.5 x
FCF Yield - - 1.44% 1.81% 2.9% 3.56% 4.45%
Price to Book 11.3 x 6.17 x 6.16 x 8.14 x 6.66 x 5.22 x 4.27 x
Nbr of stocks (in thousands) 783,465 786,659 786,126 785,719 785,719 - -
Reference price 2 69.51 44.05 50.14 78.20 74.39 74.39 74.39
Announcement Date 3/30/21 4/21/22 4/6/23 4/11/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,195 2,545 3,047 3,930 4,917 6,183 7,624
EBITDA 1 1,190 1,248 1,479 1,928 2,487 3,113 3,827
EBIT 1 1,099 1,137 1,504 1,895 2,338 2,976 3,704
Operating Margin 50.05% 44.69% 49.35% 48.23% 47.55% 48.14% 48.59%
Earnings before Tax (EBT) 1 1,097 1,136 1,501 1,893 2,361 3,000 3,718
Net income 1 939.1 973.7 1,328 1,654 2,060 2,610 3,243
Net margin 42.79% 38.25% 43.58% 42.08% 41.9% 42.21% 42.54%
EPS 2 1.252 1.239 1.689 2.104 2.622 3.321 4.128
Free Cash Flow 1 - - 559.8 1,096 1,630 1,957 2,508
FCF margin - - 18.37% 27.9% 33.15% 31.65% 32.9%
FCF Conversion (EBITDA) - - 37.85% 56.86% 65.53% 62.87% 65.54%
FCF Conversion (Net income) - - 42.16% 66.29% 79.12% 74.98% 77.32%
Dividend per Share 2 - 0.6000 0.7000 1.000 1.247 1.564 1.816
Announcement Date 3/30/21 4/21/22 4/6/23 4/11/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4
Net sales 1 - 989.3 1,865 - 1,022
EBITDA - - - - -
EBIT 1 - 459.8 865.5 501.4 528.5
Operating Margin - 46.48% 46.4% - 51.73%
Earnings before Tax (EBT) 1 - 458.8 864.3 501.3 527.5
Net income 355.1 394.9 750 - -
Net margin - 39.92% 40.21% - -
EPS 0.4517 0.5025 0.9542 - -
Dividend per Share - - - - -
Announcement Date 4/27/23 8/24/23 8/24/23 10/26/23 4/11/24
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - -
Net Cash position 1 - - 482 1,047 2,278 3,453 2,131
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - - 560 1,096 1,630 1,957 2,508
ROE (net income / shareholders' equity) 22.4% 18.9% 21.9% 23.7% 23.2% 23.9% 24.2%
ROA (Net income/ Total Assets) 21.4% 17% 18.9% - 21.3% 22.4% 22.2%
Assets 1 4,382 5,721 7,015 - 9,661 11,665 14,588
Book Value Per Share 2 6.130 7.130 8.140 9.600 11.20 14.30 17.40
Cash Flow per Share 2 1.250 0.9800 1.220 1.810 2.750 3.050 3.750
Capex 1 253 343 403 322 374 384 596
Capex / Sales 11.53% 13.46% 13.21% 8.2% 7.61% 6.21% 7.82%
Announcement Date 3/30/21 4/21/22 4/6/23 4/11/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
74.39 CNY
Average target price
84.5 CNY
Spread / Average Target
+13.58%
Consensus
  1. Stock Market
  2. Equities
  3. 300832 Stock
  4. Financials Shenzhen New Industries Biomedical Engineering Co., Ltd.